/
/
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
This content is Free Access.
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
3,238 Views
•
09:54 min
•
May 22, 2020
DOI:
Summary
Automatically generated
A protocol for studying FcγRIIIa-driven events by therapeutic antibodies in human natural killer cells is described here. This artificial stimulation platform permits the interrogation of downstream effector functions such as degranulation, chemokine/cytokine production, and signaling pathways mediated by the FcγRIIIa and Fc portions of antibodies involved in binding.
Read Article
Cite this Article
Petriello, A., Becerra, J. A., Lay, J., Husaini, R., Windler, S. L., Duramad, O., Liu, S. D. Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies. J. Vis. Exp. (159), e61144, doi:10.3791/61144 (2020).
Copy